Status In progress
Process STA pre-2018
ID number 1160

Provisional Schedule

Expected publication 05 June 2019

Project Team

Project lead Thomas Feist

Email enquiries

Evidence Review Group / Assessment Group Warwick Evidence

Consultees

Companies sponsors Merck Sharp and Dohme
Others Department of Health
  NHS England
  Welsh Government
Patient carer groups Diabetes UK
Professional groups Royal College of Physicians
  UK Clinical Pharmacy Association

Commentators

Comparator companies AstraZeneca
  Boehringer Ingelheim Ltd
  Napp Pharmaceuticals Limited
  Sanofi
Evidence review group Warwick Evidence
General commentators All Wales Therapeutics and Toxicology Centre
  BNF
  Department of Health and Social Services and Public Safety, Northern Ireland
  Healthcare Improvement Scotland
  Scottish Medicines Consortium
  Welsh Health Specialised Services Committee

Timeline

Key events during the development of the guidance:

Date Update
26 April 2019 - 13 May 2019 Final appraisal document: 1
12 March 2019 Committee meeting: 2
08 January 2019 Committee meeting: 1
01 August 2018 Invitation to participate
15 June 2018 In progress, In progress

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance